Trial Profile
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 May 2017
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Fluoxetine
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly and Company
- 18 Apr 2012 Actual patients number is 463 as reported by ClinicalTrials.gov.
- 18 Apr 2012 Actual patients number is 463 as reported by ClinicalTrials.gov.
- 12 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.